Skip to main content
Back
Watch Compare

Greenwich LifeSciences, Inc.

Data quality: 83%
GLSI
NASDAQ Manufacturing Chemicals
$25.78
▼ $0.04 (-0.15%)
Mkt Cap: 355.09 M
Price
$25.63
Mkt Cap
355.09 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -8.59 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-1074.68%
Below sector avg (-54.01%)
ROIC-853.85%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

Valuation

PE (TTM)
-18.23
Below sector avg (-1.49)
P/B Ratio162.52
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -18.2 -1.5
P/B 162.5 1.6
ROE % -1074.7 -54.0
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

2 analysts
Buy
Current
$25.78
+84.3%
Target
$47.50
$45.00
$47.50
$50.00
Forecast
Forward EPS -$1.35
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2026 -$1.35
-$1.48 – -$1.21
 0.0 2

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q32025 -$0.36 -$0.30 +16.7%
Q22025 -$0.24 -$0.30 -25.0%
Q12025 -$0.24 -$0.25 -4.2%
Q42024 -$0.21 -$0.61 -190.5%

ETFs Holding This Stock

GSCOX GSCOX
0.02% weight
GSIOX GSIOX
0.02% weight
GSTOX GSTOX
0.02% weight
GSROX GSROX
0.02% weight
GINUX GINUX
0.02% weight
GSZPX GSZPX
0.02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -19.48 M
ROE -1074.68% ROA -561.90%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -8.59 M
ROIC -853.85% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value 2.18 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -18.23 Forward P/E N/A
P/B Ratio 162.52 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -2.42%
Market Cap 355.09 M Enterprise Value 351.28 M
Per Share
EPS (Diluted TTM) -1.46 Revenue / Share N/A
FCF / Share -0.62 OCF / Share -0.62
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 44.11%
SBC-Adj. FCF -13.82 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -15.79 M -8.89 M -7.83 M -4.57 M -1.86 M
EPS (Diluted) -1.21 -0.69 — — —
Gross Profit — — — — —
Operating Income -16.01 M -9.33 M -8.04 M -4.60 M -1.86 M
EBITDA — — — — —
R&D Expenses 12.95 M 7.70 M 6.48 M 3.56 M 1.06 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 4.09 M 6.99 M 13.48 M 27.22 M 28.68 M
Total Liabilities 1.56 M 294,406.0 262,905.0 385,172.0 1.05 M
Shareholders' Equity 2.53 M 6.70 M 13.21 M 26.83 M 27.63 M
Total Debt — — — — —
Cash & Equivalents 4.09 M 6.99 M 13.47 M 27.20 M 28.66 M
Current Assets — — — — 28.66 M
Current Liabilities 1.56 M 294,406.0 262,905.0 385,172.0 1.05 M